Myth: Immunotherapy Cures All Cancers
No — immunotherapy does not cure all cancers, and no oncologist can promise a cure to any individual patient. In a proportion of patients with certain cancers, checkpoint inhibitors produce long, sometimes years-long remission, but response depends heavily on cancer type, biomarkers, and stage, and many patients see limited or no benefit at all.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist · MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Not a universal cure — immunotherapy works well for some cancers and barely at all for others; there's no single answer for everyone
- Response isn't guaranteed — biomarker tests like PD-L1 and MSI help predict who's more likely to benefit, but can't promise an outcome
- Long remission isn't the same as cure — some patients stay cancer-free for years, which doctors describe as a durable response, not a cure
- Honest expectations, set upfront — our tumour board discusses your realistic chances before treatment starts, with no inflated promises
on Panel
Survival Rate*
Treated
(800+ reviews)
Can immunotherapy cure cancer?
No treatment, including immunotherapy, can promise a cure for cancer, and immunotherapy is no exception. What it can do, in a proportion of patients with specific cancers and biomarkers, is trigger the immune system to control or shrink tumours for an extended period — sometimes for years. Oncologists call this a durable response, and it is deliberately not the same word as cure.
Headlines describing immunotherapy as a "breakthrough" or a "miracle" summarise the most striking clinical trial results, not the typical patient's outcome. Those stories are real, but they are the exception being reported precisely because they are exceptional — most coverage doesn't have room to explain the full range of outcomes, including patients for whom the same drug did very little.
Part of the confusion is the name itself: "immunotherapy" sounds like it simply boosts your immunity, the way a supplement or diet change might. In reality, it's a precise, prescription-only drug treatment that blocks specific signals cancer cells use to hide from the immune system — a targeted mechanism, not a general immunity boost.
Did you know?
In advanced melanoma and certain lung cancers, some patients treated with checkpoint inhibitors have maintained a durable response for five years or more in published clinical trials. This outcome is genuinely encouraging, but it does not occur for most patients or most cancer types. (Source: NCCN and ASCO immunotherapy guidance, 2024.)
What proportion of patients respond to immunotherapy?
Response depends enormously on the specific cancer type and its biomarkers — there is no single number that applies to everyone. This table shows the pattern, not a prediction for any one patient.
Patterns follow NCCN and ASCO treatment guidance. Only a review of your own reports and biomarkers can tell you what to realistically expect — use this table to understand the picture, not to predict your own outcome.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get facts, not false hope
Speak to a CION oncology team member for an honest, personalised view of what immunotherapy can — and can't — do for you.
Where does the "immunotherapy cures all cancers" myth come from?
Media coverage has created expectations no single treatment can meet. None of these sources are dishonest on their own — the problem is what gets left out.
Breakthrough headlines
News stories about a single patient's remarkable recovery are newsworthy precisely because they are unusual, not because they are typical.
"Immune" sounds familiar
The word immunotherapy sounds like it simply boosts the immune system the way a supplement might. The reality is a precise, drug-based treatment that unblocks specific immune signalling.
Social media testimonials
Individual success stories shared online are real but selective — they rarely mention the patients for whom the same treatment didn't work as well.
A word families want to be true
For a family facing a cancer diagnosis, "cure" is the word everyone hopes to hear, which makes hopeful headlines especially easy to believe.
What does "response" mean, if not cure?
Oncologists use specific terms that describe outcomes more precisely than "cure" — each one means something different for what happens next.
- Complete response — no detectable cancer on scans, though monitoring continues, since microscopic disease can remain undetected.
- Partial response — the tumour has shrunk significantly but hasn't disappeared.
- Stable disease — the cancer has stopped growing, without shrinking further.
- Durable response — a response, complete or partial, that lasts for an extended period, sometimes years.
- Progression — the cancer continues to grow despite treatment, which happens in a meaningful proportion of patients.
Which of these applies to you depends on your specific cancer type, its biomarkers, and how it responds — something only testing and a tumour board review can tell you. For some patients, after weighing side effects against expected benefit, the right decision is not to pursue immunotherapy at all. That is a legitimate option your oncologist should discuss with you, not a failure.
Correcting the wider "immunity" confusion
- Is Immunotherapy the Same as an Immunity Injection or Drip? — clears up the name confusion that helps this myth spread in the first place.
- Ayurvedic and Homeopathic "Immunotherapy": What Is Being Offered — if you've been offered an "immunity-boosting" therapy under a similar name, it's worth understanding exactly what it is before combining it with prescribed treatment.
- Myth: Sugar Feeds Cancer, So Starve It — another widely believed idea that doesn't hold up to how cancer treatment actually works.
- Immunotherapy at CION Cancer Clinics — the full picture of how CION supports patients through immunotherapy, from candidacy to side-effect care.
This page is for general information and does not replace a consultation. If you're weighing whether immunotherapy is right for your specific diagnosis, discuss it directly with your oncology team.
Thousands of families have asked us this same question
Understanding what immunotherapy can realistically offer is the first step to making a confident treatment decision.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.